HALMSTAD, Sweden, Dec. 08, 2023 (GLOBE NEWSWIRE) -- Redsense Medical AB (OTCQX: RDSNF | Spotlight: REDS), based in Sweden, focused on monitoring of blood leakage during hemodialyis to increase patient safety, today announced that Pontus Nobréus, CEO, will present live at the Life Science Investor Forum, hosted by VirtualInvestorConferences.com, on December 14th, 2023.
DATE: December 14th , 2023
TIME: 9:30 AM ET
LINK: https://bit.ly/3FgGsBt
Available for 1x1 meetings: December 14th, December 15th, December 18th and December 19th
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.virtualinvestorconferences.com.
Recent Company Highlights
- Interim Report Q3, January – September, 2023
- Redsense Medical AB’s shares to begin trading at OTCQX on September 29, 2023
- Redsense Medical arranged Congressional Briefing to address Venous Needle Dislodgement
- Redsense secures strong autumn with MSEK 11.2 order
- Redsense Medical’s alarm system featured in KFF Health News
About Redsense Medical
Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovation used for monitoring and alarm in the case of blood leakage in connection with a hemodialysis treatment. Redsense Medical solves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter leakage to minimize blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector. The Redsense Medical share is listed on Spotlight Stock Market (REDS) and traded on OTCQX (RDSNF) in the US.
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
CONTACTS:
Redsense Medical AB
Pontus Nobréus
CEO
+46 721 711264
pontus.nobreus@redsensemedical.com
Virtual Investor Conferences
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
johnv@otcmarkets.com
